Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409

Jan. 10, 2012

Novel approach leads to discovery of NME that prevents tumor invasion

Jan. 10, 2012

New auristatin derivatives for cancer prepared at Bayer Schering Pharma

Jan. 10, 2012

First patient vaccinated in study of DPX-Survivac cancer vaccine

Jan. 9, 2012

Novel protein-tyrosine kinase inhibitors synthesized in China

Jan. 9, 2012

Phase I/II study evaluates rintatolimod as adjuvant for HER2 vaccine

Jan. 9, 2012

Dosing of VT-464 begins in phase I/II study

Jan. 9, 2012

University of Arizona scientists assess natural monoterpene in phase I trial

Jan. 9, 2012

Presurgical trial set to investigate MK-2206 in operable invasive cancer

Jan. 9, 2012

Alchemia treats first patient in pivotal phase III HA-irinotecan trial

Jan. 5, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026